FDA Approves METFORMIN HYDROCHLORIDE — Westminster Pharmaceuticals, LLC
Westminster Pharmaceuticals, LLC announced final FDA approval today for its ANDA 203769, aiming to introduce metformin hydrochloride tablets to the market. This move positions the company to compete for market share within the ubiquitous diabetes treatment segment.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day